|
This story is from the category The Brain
Date posted: 30/01/2009 European regulators have given a green light to St. Jude Medical to market the company's Libra? and LibraXP deep brain stimulation (DBS) systems for treatment of symptoms of Parkinson's disease. The Libra DBS systems function in a manner similar to a heart pacemaker by delivering mild electrical pulses from an implanted device to stimulate structures in the brain that are involved in muscle and movement control. Stimulation is delivered to one of two regions in the brain known as the subthalamic nucleus (STN) or the globus pallidus interna (GPi) to influence nerve cell activity in these regions. "The approval of our first deep brain stimulation system represents the fulfillment of a milestone for St. Jude Medical as we continue to deliver on our promise to develop therapies to treat neurological conditions," said Chris Chavez, president of the St. Jude Medical Neuromodulation Division. See the full Story via external site: phx.corporate-ir.net Most recent stories in this category (The Brain): 04/02/2017: HKU scientists utilise innovative neuroimaging approach to unravel complex brain networks |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
